Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00676585 · ClinicalTrials.gov registry record · Phase 1
Corticosteroid Therapy in Refractory Shock Following Cardiac Arrest
A Phase 1 study of Cardiac Arrest, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT00676585 is a Phase 1 study of Cardiac Arrest that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 50 participants, below the 1,478-participant average among 31 other Cardiac Arrest trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00676585, a Phase 1 study of Cardiac Arrest, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The major goal of this project is to determine whether the use of physiologic doses of corticosteroids will decrease time to shock reversal, alters the inflammatory cascade, and alters microcirculatory flow in post-cardiac arrest patients.
Conditions Studied
Interventions
- DRUG Hydrocortisone
- DRUG Normal Saline
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2007-10 |
| Est. Completion | 2014-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00676585
The ClinicalTrials.gov registry entry for NCT00676585 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,478-participant average among 31 other Cardiac Arrest trials with a reported enrollment target (97% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiac Arrest appearing as the primary indexed condition, and to 2 interventions - of which Hydrocortisone is the first listed.
NCT00676585 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00676585 about?
NCT00676585 is a clinical study titled "Corticosteroid Therapy in Refractory Shock Following Cardiac Arrest". The major goal of this project is to determine whether the use of physiologic doses of corticosteroids will decrease time to shock reversal, alters the inflammatory cascade, and alters microcirculatory flow in post-cardiac arrest patients.
What is the current status of trial NCT00676585?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2007-10. Estimated completion is 2014-04.
What conditions does trial NCT00676585 study?
This clinical trial studies the following conditions: Cardiac Arrest.
What interventions are being tested in trial NCT00676585?
The interventions under investigation include: Hydrocortisone (DRUG), Normal Saline (DRUG).
Who is sponsoring clinical trial NCT00676585?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00676585 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Arrest
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Post-CA Neuroprotection With Magnesium
RECRUITING · Phase 1
-
Hydrogen's Feasibility and Safety as a Therapy in ECPR
RECRUITING · Phase 1
-
Packed Red Blood Cell Transfusion During Cardiac Arrest
RECRUITING · Phase 1
-
Washington Study of Hemofiltration After Out-of-Hospital Cardiac Arrest
COMPLETED · Phase 1
-
Trial of Vasopressin and Epinephrine to Epinephrine Only for In-Hospital Pediatric Cardiopulmonary Resuscitation
COMPLETED · Phase 1
-
Reoxygenation After Cardiac Arrest II (REOX II Study)
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.